Chairman's - FMC Corporation
Chairman's - FMC Corporation
Chairman's - FMC Corporation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Specialty Chemicals<br />
Financial Information (In Millions)<br />
$1000<br />
$750<br />
$500<br />
$250<br />
Specialty Chemicals:<br />
Revenue and Operating Margin<br />
2005-2009<br />
559<br />
19%<br />
Revenue Operating Margin<br />
593<br />
20%<br />
660<br />
22%<br />
765 753<br />
20%<br />
21%<br />
40%<br />
30%<br />
20%<br />
10%<br />
$0 0%<br />
Overview<br />
Specialty Chemicals:<br />
Capital Expenditures and Depreciation and<br />
Amortization 2005-2009<br />
$70<br />
$60<br />
$50<br />
$40<br />
$30<br />
$20<br />
$10<br />
$0<br />
Capital Expenditure<br />
Depreciation and Amortization<br />
30 32<br />
34<br />
31 31 32 33 34<br />
2005 2006 2007 2008 2009 2005 2006 2007 2008 2009<br />
Our Specialty Chemicals segment, which represents 27 percent of our 2009 consolidated revenues, is<br />
focused on high-performance food ingredients, pharmaceutical excipients and encapsulants, biomedical<br />
technologies and lithium specialty products, all of which enjoy solid customer bases and consistent, growing<br />
demand. The significant majority of Specialty Chemicals sales are to customers in non-cyclical end markets. We<br />
believe that our future growth in this segment will continue to be based on the value-added performance<br />
capabilities of these products and our research and development capabilities, as well as on the alliances and the<br />
close working relationships we have developed with key global customers.<br />
Products and Markets<br />
Lithium<br />
Specialty Chemicals: Specialty Chemicals:<br />
2009 Sales Mix 2009 Revenue by Region<br />
23%<br />
77%<br />
Bio Europe, Middle<br />
Polymer East & Africa<br />
9<br />
Latin America<br />
8%<br />
Asia Pacific North<br />
20%<br />
40%<br />
America<br />
32%<br />
46<br />
66